Femring and disease recurrence Patient Reports February 10, 2012

Femring Side Effects Report #5489147-9
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 01, 2007. Female patient, 34 years of age, weighting 115.1 lb, was diagnosed with vulvovaginal discomfort, vulvovaginal dryness and was treated with Femring. After drug was administered, patient experienced the following side effects: anxiety , autonomic nervous system imbalance, chest pain , decreased appetite, depression , disease recurrence, dizziness , hormone level abnormal. Femring dosage: 0.1 MG, QD, VAGINAL; 0.1 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR, CARDIZEM, PREMARIN, REMERON. Patient was hospitalized. Patient recovered.

Femring Side Effects Report #5348678-2
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, 49 years of age, weighting 175.0 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: disease recurrence, hysterectomy , menopausal symptoms, upper respiratory tract infection. Femring dosage: 0.05 MG, QD, VAGINAL RING. During the same period patient was treated with CYMBALTA, PREVACID, PREDNISONE, ALPRAZOLAM, HYDROCODONE, PERCOCET. Patient was hospitalized. Patient recovered.

Femring Side Effects Report #5449522-5
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Female patient, 40 years of age, weighting 119.9 lb, was diagnosed with artificial menopause and was treated with Femring. After drug was administered, patient experienced the following side effects: disease recurrence, rheumatoid arthritis , vulvovaginal mycotic infection. Femring dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID. Patient recovered.